Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Ferrand

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Molecular Cell|August 19, 2006
Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signalingSu Ryeon Seo, Nathalie Ferrand, Nourdine Faresse, et al.
The Journal of Biological Chemistry|June 11, 2005
AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanismFrançois Lallemand, Su Ryeon Seo, Nathalie Ferrand, et al.
Oncotarget|June 5, 2015
Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitorsMeriam Ayadi, Anaïs Bouygues, Djamila Ouaret, et al.
The Journal of Cell Biology|July 11, 2007
The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptorAzeddine Atfi, Emmanuelle Dumont, Frédéric Colland, et al.
Molecular and Cellular Biology|January 26, 2011
CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathwayMichèle Sabbah, Céline Prunier, Nathalie Ferrand, et al.
Cancers|December 19, 2019
Breast-Associated Adipocytes Secretome Induce Fatty Acid Uptake and Invasiveness in Breast Cancer Cells via CD36 Independently of Body Mass Index, Menopausal Status and Mammary DensityMaurice Zaoui, Mehdi Morel, Nathalie Ferrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> StatusPaul Mésange, Anaïs Bouygues, Nathalie Ferrand, et al.
Marine Drugs|April 9, 2020
Secondary Metabolites from the Culture of the Marine-derived Fungus <i>Paradendryphiella salina</i> PC 362H and Evaluation of the Anticancer Activity of Its Metabolite HyalodendrinAmbre Dezaire, Christophe H Marchand, Marine Vallet, et al.
Cells, Tissues, Organs|October 27, 2024
Impact of Fetal Umbilical Cord Blood CD34+ Cells on Breast Cancer Cell Lines: A Mechanism of Fetal MicrochimerismKamila Kolanska, Merwane Roche, Camille Carrière, et al.
Cell Reports|August 6, 2013
Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivationAsma Ettahar, Olivier Ferrigno, Ming-Zhu Zhang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cell|August 19, 2006
Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signalingSu Ryeon Seo, Nathalie Ferrand, Nourdine Faresse, et al.
The Journal of Biological Chemistry|June 11, 2005
AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanismFrançois Lallemand, Su Ryeon Seo, Nathalie Ferrand, et al.
Oncotarget|June 5, 2015
Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitorsMeriam Ayadi, Anaïs Bouygues, Djamila Ouaret, et al.
The Journal of Cell Biology|July 11, 2007
The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptorAzeddine Atfi, Emmanuelle Dumont, Frédéric Colland, et al.
Molecular and Cellular Biology|January 26, 2011
CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathwayMichèle Sabbah, Céline Prunier, Nathalie Ferrand, et al.
Cancers|December 19, 2019
Breast-Associated Adipocytes Secretome Induce Fatty Acid Uptake and Invasiveness in Breast Cancer Cells via CD36 Independently of Body Mass Index, Menopausal Status and Mammary DensityMaurice Zaoui, Mehdi Morel, Nathalie Ferrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of <i>RAS</i> StatusPaul Mésange, Anaïs Bouygues, Nathalie Ferrand, et al.
Marine Drugs|April 9, 2020
Secondary Metabolites from the Culture of the Marine-derived Fungus <i>Paradendryphiella salina</i> PC 362H and Evaluation of the Anticancer Activity of Its Metabolite HyalodendrinAmbre Dezaire, Christophe H Marchand, Marine Vallet, et al.
Cells, Tissues, Organs|October 27, 2024
Impact of Fetal Umbilical Cord Blood CD34+ Cells on Breast Cancer Cell Lines: A Mechanism of Fetal MicrochimerismKamila Kolanska, Merwane Roche, Camille Carrière, et al.
Cell Reports|August 6, 2013
Identification of PHRF1 as a tumor suppressor that promotes the TGF-β cytostatic program through selective release of TGIF-driven PML inactivationAsma Ettahar, Olivier Ferrigno, Ming-Zhu Zhang, et al.
Pageof 4